Pricing
Login
Home
Charts
Search
Watchlist
Products

Wockhardt Ltd

WOCKPHARMA
₹2,184.40-0.12%20 Nov 2026
Reports
Pharma Formulations

Wockhardt Ltd

WOCKPHARMA
₹2,184.40
-0.12%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹35,499Cr
Close
Close Price
₹2,184.40
Industry
Industry
Pharma Formulations
PE
Price To Earnings
86.55
PS
Price To Sales
9.46
Revenue
Revenue
₹3,751Cr
Rev Gr TTM
Revenue Growth TTM
25.70%
PAT Gr TTM
PAT Growth TTM
894.12%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
701700739809721743738782888965929969
Growth YoY
Revenue Growth YoY%
0.33.214.87.42.96.1-0.1-3.323.229.925.923.9
Expenses
ExpensesCr
664803648699593679666604711740737796
Operating Profit
Operating ProfitCr
37-103911101286472178177225192173
OPM
OPM%
5.3-14.712.313.617.88.69.822.819.923.320.717.9
Other Income
Other IncomeCr
854309815-772115673111
Interest Expense
Interest ExpenseCr
777373736048485560505256
Depreciation
DepreciationCr
555854555553565365535555
PBT
PBTCr
-87-180-6-921-22-109916718911673
Tax
TaxCr
-1-3107123-1962590
PAT
PATCr
-86-177-16-1620-45-108826116410773
Growth YoY
PAT Growth YoY%
15.725.388.278.1123.374.6-575.0612.5205.0464.4199.1-11.0
NPM
NPM%
-12.3-25.3-2.2-2.02.8-6.1-14.610.56.917.011.57.5
EPS
EPS₹
-5.8-11.6-0.9-1.50.9-1.6-5.54.83.610.26.54.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
701700739809721743738782888965929969
Growth YoY
Revenue Growth YoY%
0.33.214.87.42.96.1-0.1-3.323.229.925.923.9
Expenses
ExpensesCr
664803648699593679666604711740737796
Operating Profit
Operating ProfitCr
37-103911101286472178177225192173
OPM
OPM%
5.3-14.712.313.617.88.69.822.819.923.320.717.9
Other Income
Other IncomeCr
854309815-772115673111
Interest Expense
Interest ExpenseCr
777373736048485560505256
Depreciation
DepreciationCr
555854555553565365535555
PBT
PBTCr
-87-180-6-921-22-109916718911673
Tax
TaxCr
-1-3107123-1962590
PAT
PATCr
-86-177-16-1620-45-108826116410773
Growth YoY
PAT Growth YoY%
15.725.388.278.1123.374.6-575.0612.5205.0464.4199.1-11.0
NPM
NPM%
-12.3-25.3-2.2-2.02.8-6.1-14.610.56.917.011.57.5
EPS
EPS₹
-5.8-11.6-0.9-1.50.9-1.6-5.54.83.610.26.54.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4,4534,0153,9373,5662,8442,7083,2302,6512,7983,0123,3733,751
Growth
Revenue Growth%
-0.6-9.8-1.9-9.4-20.2-4.819.3-17.95.57.712.025.7
Expenses
ExpensesCr
3,9594,0023,9353,6042,7252,7712,9322,5502,7592,6192,7212,984
Operating Profit
Operating ProfitCr
494132-38119-6329810139393652767
OPM
OPM%
11.10.30.1-1.14.2-2.39.23.81.413.119.320.4
Other Income
Other IncomeCr
66114-2382139-10-163-172696226124
Interest Expense
Interest ExpenseCr
129225255265276249299302305254213218
Depreciation
DepreciationCr
142149150164224246247251223217227228
PBT
PBTCr
289-247-641-447-342-568-411-624-420-16238445
Tax
TaxCr
38-2126-135-204-271-132-352413940
PAT
PATCr
252-226-667-312-138-297-279-621-472-57199405
Growth
PAT Growth%
-39.0-189.8-195.053.255.8-115.36.1-122.624.087.9449.1894.1
NPM
NPM%
5.7-5.6-16.9-8.7-4.8-11.0-8.6-23.4-16.9-1.95.910.8
EPS
EPS₹
20.9-16.3-50.7-40.3-5.857.1-20.2-38.8-32.0-3.013.125.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4,4534,0153,9373,5662,8442,7083,2302,6512,7983,0123,3733,751
Growth
Revenue Growth%
-0.6-9.8-1.9-9.4-20.2-4.819.3-17.95.57.712.025.7
Expenses
ExpensesCr
3,9594,0023,9353,6042,7252,7712,9322,5502,7592,6192,7212,984
Operating Profit
Operating ProfitCr
494132-38119-6329810139393652767
OPM
OPM%
11.10.30.1-1.14.2-2.39.23.81.413.119.320.4
Other Income
Other IncomeCr
66114-2382139-10-163-172696226124
Interest Expense
Interest ExpenseCr
129225255265276249299302305254213218
Depreciation
DepreciationCr
142149150164224246247251223217227228
PBT
PBTCr
289-247-641-447-342-568-411-624-420-16238445
Tax
TaxCr
38-2126-135-204-271-132-352413940
PAT
PATCr
252-226-667-312-138-297-279-621-472-57199405
Growth
PAT Growth%
-39.0-189.8-195.053.255.8-115.36.1-122.624.087.9449.1894.1
NPM
NPM%
5.7-5.6-16.9-8.7-4.8-11.0-8.6-23.4-16.9-1.95.910.8
EPS
EPS₹
20.9-16.3-50.7-40.3-5.857.1-20.2-38.8-32.0-3.013.125.2
Sales CAGR
1 Year12%
3 Years8%
5 Years4%
TTM26%
EBITDA CAGR
1 Year66%
3 Years86%
5 Years-
TTM74%
Avg. ROCE
1 Year6%
3 Years3%
5 Years0%
TTM9%
CFO / EBITDA
1 Year60%
3 Years54%
5 Years78%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555555555727277818181
Reserves
ReservesCr
3,7203,2812,7972,6192,6163,3213,7773,2823,2824,2724,8595,077
Current Liabilities
Current LiabilitiesCr
1,8421,9792,6922,8643,4973,1213,2073,4352,7912,0421,6221,785
Non Current Liabilities
Non Current LiabilitiesCr
2,0393,3242,2721,9761,6248948345861,1961,4361,7121,617
Total Liabilities
Total LiabilitiesCr
8,1219,0228,1627,8448,1797,7748,2437,6837,6498,1358,6158,902
Current Assets
Current AssetsCr
3,9524,5353,3802,8152,4302,4252,5892,2082,0732,4652,6062,790
Non Current Assets
Non Current AssetsCr
4,1694,4864,7825,0305,7495,3495,6545,4755,5765,6706,0096,112
Total Assets
Total AssetsCr
8,1219,0228,1627,8448,1797,7748,2437,6837,6498,1358,6158,902
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555555555555727277818181
Reserves
ReservesCr
3,7203,2812,7972,6192,6163,3213,7773,2823,2824,2724,8595,077
Current Liabilities
Current LiabilitiesCr
1,8421,9792,6922,8643,4973,1213,2073,4352,7912,0421,6221,785
Non Current Liabilities
Non Current LiabilitiesCr
2,0393,3242,2721,9761,6248948345861,1961,4361,7121,617
Total Liabilities
Total LiabilitiesCr
8,1219,0228,1627,8448,1797,7748,2437,6837,6498,1358,6158,902
Current Assets
Current AssetsCr
3,9524,5353,3802,8152,4302,4252,5892,2082,0732,4652,6062,790
Non Current Assets
Non Current AssetsCr
4,1694,4864,7825,0305,7495,3495,6545,4755,5765,6706,0096,112
Total Assets
Total AssetsCr
8,1219,0228,1627,8448,1797,7748,2437,6837,6498,1358,6158,902

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-42-26968183649-287413153219-22390
Investing Cash Flow
Investing Cash FlowCr
-106-68763095-1561,470-201-125-137-783-241
Financing Cash Flow
Financing Cash FlowCr
1931,254-769-776-680-1,171-71-315334409-54
Net Cash Flow
Net Cash FlowCr
46298-71-499-18612141-287416-39695
Free Cash Flow
Free Cash FlowCr
-105-678-238-86627-367296190226-106304
CFO To PAT
CFO To PAT%
-16.5119.2-10.3-58.8-470.496.6-148.0-24.6-46.438.6196.0
CFO To EBITDA
CFO To EBITDA%
-8.4-2,105.23,739.9-476.4545.2455.6138.6151.5561.5-5.659.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-42-26968183649-287413153219-22390
Investing Cash Flow
Investing Cash FlowCr
-106-68763095-1561,470-201-125-137-783-241
Financing Cash Flow
Financing Cash FlowCr
1931,254-769-776-680-1,171-71-315334409-54
Net Cash Flow
Net Cash FlowCr
46298-71-499-18612141-287416-39695
Free Cash Flow
Free Cash FlowCr
-105-678-238-86627-367296190226-106304
CFO To PAT
CFO To PAT%
-16.5119.2-10.3-58.8-470.496.6-148.0-24.6-46.438.6196.0
CFO To EBITDA
CFO To EBITDA%
-8.4-2,105.23,739.9-476.4545.2455.6138.6151.5561.5-5.659.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,7547,9598,0354,9031,9134,5903,8002,2188,95223,13419,12935,499
Price To Earnings
Price To Earnings
42.96.689.586.5
Price To Sales
Price To Sales
2.42.02.01.40.71.71.20.83.27.75.79.5
Price To Book
Price To Book
2.92.42.81.80.71.41.00.72.75.33.96.9
EV To EBITDA
EV To EBITDA
23.8797.65,225.7-179.534.9-110.718.842.4276.463.532.448.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
55.951.448.947.250.449.652.549.549.553.057.157.1
OPM
OPM%
11.10.30.1-1.14.2-2.39.23.81.413.119.320.4
NPM
NPM%
5.7-5.6-16.9-8.7-4.8-11.0-8.6-23.4-16.9-1.95.910.8
ROCE
ROCE%
6.7-0.3-7.1-3.5-1.3-5.3-1.9-5.8-2.03.76.39.1
ROE
ROE%
6.7-6.8-23.4-11.7-5.2-8.8-7.3-18.5-14.1-1.34.07.8
ROA
ROA%
3.1-2.5-8.2-4.0-1.7-3.8-3.4-8.1-6.2-0.72.34.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,7547,9598,0354,9031,9134,5903,8002,2188,95223,13419,12935,499
Price To Earnings
Price To Earnings
42.96.689.586.5
Price To Sales
Price To Sales
2.42.02.01.40.71.71.20.83.27.75.79.5
Price To Book
Price To Book
2.92.42.81.80.71.41.00.72.75.33.96.9
EV To EBITDA
EV To EBITDA
23.8797.65,225.7-179.534.9-110.718.842.4276.463.532.448.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
55.951.448.947.250.449.652.549.549.553.057.157.1
OPM
OPM%
11.10.30.1-1.14.2-2.39.23.81.413.119.320.4
NPM
NPM%
5.7-5.6-16.9-8.7-4.8-11.0-8.6-23.4-16.9-1.95.910.8
ROCE
ROCE%
6.7-0.3-7.1-3.5-1.3-5.3-1.9-5.8-2.03.76.39.1
ROE
ROE%
6.7-6.8-23.4-11.7-5.2-8.8-7.3-18.5-14.1-1.34.07.8
ROA
ROA%
3.1-2.5-8.2-4.0-1.7-3.8-3.4-8.1-6.2-0.72.34.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr44,35141,45838,67735,49928,45122,44020,461
Close PriceClose₹2,337.803,317.702,408.902,184.401,718.70822.651,040.95
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE40.5432.8253.2286.5587.0728.4724.25
Price To SalesPS4.336.679.329.4613.553.812.41
RevenueRevenueCr10,2346,2174,1483,7512,1005,8958,477
Revenue Growth TTMRev Gr TTM%21.1%25.0%5.9%25.7%46.3%21.8%19.7%
PAT Growth TTMPAT Gr TTM%33.3%29.7%7.6%894.1%89.4%39.1%32.9%
Market CapitalizationMkt CapCr44,35141,45838,67735,49928,45122,44020,461
Close PriceClose₹2,337.803,317.702,408.902,184.401,718.70822.651,040.95
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE40.5432.8253.2286.5587.0728.4724.25
Price To SalesPS4.336.679.329.4613.553.812.41
RevenueRevenueCr10,2346,2174,1483,7512,1005,8958,477
Revenue Growth TTMRev Gr TTM%21.1%25.0%5.9%25.7%46.3%21.8%19.7%
PAT Growth TTMPAT Gr TTM%33.3%29.7%7.6%894.1%89.4%39.1%32.9%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews